The SUSTAIN-6 trial showed a significant reduction in major adverse cardiovascular events (MACE), including non-fatal myocardial infarction and non-fatal stroke, specifically in patients with type 2 diabetes and established cardiovascular disease or multiple cardiovascular risk factors
Thursdays vote tally reflected the unusual makeup of the panel
What they found was cost dominates treatment decisions: 68% said cost influenced their decision to start or continue treatment 44% said the medication cost more than they expected Cost surpassed side effects as the #1 reason people stopped taking GLP-1s A breakdown of the financial burden: 24% pay more than $250 per prescription fill Nearly 8% pay $500 or more per fill 24% said insurance didn't cover any cost Weight management patients were nearly twice as likely to pay $250+ vs diabetes patients --- Here's what patients are thinking: Nearly 40% ended up using discount programs or manufacturer coupons 60% know someone who wants GLP-1s but can't afford them 83% believe Americans turn to DTC programs because traditional healthcare is too expensive Patients still prioritize safety: 60% are aware of safety risks with non-FDA-approved GLP-1s--this one surprised me

Body Contouring Procedures to Consider After Weight Loss Laser Liposuction Laser liposuction, or SmartLipo, is the gold standard in liposuction to remove pockets of fat in areas like the abdomen, love handles, thighs, back, and arms
The Treasury Judgment Fund, which processes payments, was also suspended, leaving thousands of claimants in limbo
They are also combining GLP-1s for fat loss with muscle-preserving medications, so for a different mechanism of action in obesity and type 2 diabetes